Cardiotoxicity Associated with Trastuzumab Therapy in Taiwan: A Single Medical Center's 5-Year Experience

Introduction: Trastuzumab, a recombinant humanized monoclonal antibody, targets the external domain of HER2 to improve the efficacy of HER2-positive breast cancer treatment and inhibit carcinoma cellular proliferation. The purpose of this study was to identify early changes in cardiac function and d...

Full description

Bibliographic Details
Main Authors: Che-Ming Chang, Fiona Tsui-Fen Cheng, Tsen-Long Yang, Wu-Chin Wen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-06-01
Series:Journal of Cancer Research and Practice
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2311300616300702